|
| 36287571 | A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary. | J Pathol | 2023 |
| 37106553 | Lung neuroendocrine neoplasms: a single centre surgical series and analysis of staging. | ANZ J Surg | 2023 |
| 36910116 | Suggested robotic-assisted thoracic surgery training curriculum. | J Thorac Dis | 2023 |
| 36669791 | Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors. | J Immunother Cancer | 2023 |
| 36030832 | Use of Indocyanine Green Fluorescence Imaging in Thoracic and Esophageal Surgery. | Ann Thorac Surg | 2023 |
| 34676962 | A comparison of outcomes and survival between Victoria and Denmark in lung cancer surgery: opportunities for international benchmarking. | ANZ J Surg | 2022 |
| 35792882 | A Cathepsin-Targeted Quenched Activity-Based Probe Facilitates Enhanced Detection of Human Tumors during Resection. | Clin Cancer Res | 2022 |
| 35761341 | Australasian Malignant PLeural Effusion (AMPLE)-3 trial: study protocol for a multi-centre randomised study comparing indwelling pleural catheter (±talc pleurodesis) versus video-assisted thoracoscopic surgery for management of malignant pleural effusion. | Trials | 2022 |
| 35818677 | Surgical resection of chest wall sarcomas: an analysis of survival and predictors of outcome at an Australian multidisciplinary sarcoma service. | ANZ J Surg | 2022 |
| 35623676 | Response to Letter: Beyond "Personalized" to "Tumoralized" Therapy. | J Thorac Oncol | 2022 |
| 36038161 | Development of an Australia and New Zealand Lung Cancer Clinical Quality Registry: a protocol paper. | BMJ Open | 2022 |
| 35280477 | Thoracic surgery in Australia. | J Thorac Dis | 2022 |
| 35039313 | Effect of a postoperative home-based exercise and self-management programme on physical function in people with lung cancer (CAPACITY): protocol for a randomised controlled trial. | BMJ Open Respir Res | 2022 |
| 34923204 | Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort study. | Lung Cancer | 2022 |
| 33440749 | Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too Late. | Diagnostics (Basel) | 2021 |
| 33853389 | Pulmonary carcinoid tumours: A multi-centre analysis of survival and predictors of outcome following sublobar, lobar, and extended pulmonary resections. | Asian Cardiovasc Thorac Ann | 2021 |
| 33569195 | A predictive model for identifying candidates for adjuvant chemotherapy based on recurrence risk profile of resected, node-negative (N0) non-small cell lung cancer. | J Thorac Dis | 2021 |
| 33870609 | Long-term outcomes of pulmonary metastasectomy: a multicentre analysis. | ANZ J Surg | 2021 |
| 33845213 | Genomic and Clinical Significance of Multiple Primary Lung Cancers as Determined by Next-Generation Sequencing. | J Thorac Oncol | 2021 |
| 34461484 | Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians. | ESMO Open | 2021 |
| 34046489 | Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era? | ERJ Open Res | 2021 |
| 34127383 | EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer. | Clin Lung Cancer | 2021 |
| 34012481 | Prognostic utility of inflammation-based biomarkers, neutrophil-lymphocyte ratio and change in neutrophil-lymphocyte ratio, in surgically resected lung cancers. | Ann Thorac Med | 2021 |
| 32379503 | Tubeless video-assisted thoracic surgery for lung cancer: is it ready for prime time? | Future Oncol | 2020 |
| 31955319 | Novel technique for parietal pleural dissection using a laparoscopic hernia balloon. | Gen Thorac Cardiovasc Surg | 2020 |
| 33122723 | SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer. | Sci Rep | 2020 |
| 33262203 | Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians. | ESMO Open | 2020 |
| 32953541 | Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team. | Transl Lung Cancer Res | 2020 |
| 32447995 | Attitudes and Perceptions to Prehabilitation in Lung Cancer. | Integr Cancer Ther | 2020 |
| 32545367 | TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. | Cancers (Basel) | 2020 |
| 30579847 | Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia. | Ann Thorac Surg | 2019 |
| 31522515 | Endobronchial metastases from hepatocellular carcinoma: a case report. | Asian Cardiovasc Thorac Ann | 2019 |
| 31519898 | Distinct initiating events underpin the immune and metabolic heterogeneity of KRAS-mutant lung adenocarcinoma. | Nat Commun | 2019 |
| 31007891 | Excision of Giant Schwannoma in a Nonagenarian-operative techniques for enhanced recovery after thoracotomy in the high-risk patient. | J Surg Case Rep | 2019 |
| 30971647 | The Past, Present and Future of Pulmonary Metastasectomy: A Review Article. | Ann Thorac Cardiovasc Surg | 2019 |
| 31106127 | Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort. | Transl Lung Cancer Res | 2019 |
| 29175115 | Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer. | J Thorac Oncol | 2018 |
| 30211472 | Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. | ANZ J Surg | 2018 |
| 30206043 | Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System. | Clin Lung Cancer | 2018 |
| 30442588 | Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). | Lancet Respir Med | 2018 |
| 30277303 | Outcomes following resection of non-small cell lung cancer in octogenarians. | ANZ J Surg | 2018 |
| 29535388 | Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. | Nat Commun | 2018 |
| 29367758 | The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53. | Oncogene | 2018 |
| 27913044 | Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens. | Pathology | 2017 |
| 28105777 | Lung cancer and socio-economic status: inextricably linked to place of residence. | Intern Med J | 2017 |
| 29221303 | The Society for Translational Medicine: clinical practice guidelines for the postoperative management of chest tube for patients undergoing lobectomy. | J Thorac Dis | 2017 |
| 29088766 | Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer. | Oncotarget | 2017 |
| 28811082 | Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients. | Pathology | 2017 |
| 28879441 | EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma. | Med Oncol | 2017 |
| 28611104 | Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma. | Mol Cancer Ther | 2017 |